News & Events
All News
-
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
September 04, 2019 -
Novo Nordisk to award promising start-ups free space at Boston's premier, biotech-capable shared lab facility
August 15, 2019 -
Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
July 17, 2019 -
LabCentral Alum, rare disease biotech Fulcrum Therapeutics sets terms for $77 million IPO
July 09, 2019 -
#OfficeEnvy: How LabCentral Designs For Scientific Collaboration
BostonInno
July 03, 2019
-
Bristol Myers-Squibb LabCentral 'Golden Ticket' Submission
July 03, 2019 -
Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency
June 27, 2019 -
LabCentral 2018 Impact Report: Resident Companies Raised the Equivalent of 40% of Early Life Sciences VC Funding in Massachusetts and 6% of U.S. Life Sciences IPOs
May 07, 2019 -
How one company thinks unraveling cough can provide a new way to treat pain
STAT April 17, 2019 -
EnClear Therapies Announces Seed Funding and Senior R&D Appointment
March 14, 2019